IDEAYA Biosciences Market Sentiment

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

$40.11

-1.66-3.97%

가까이에: Aug 28, 5:00 PM EST

$40.11

N/A

시간외: 4:00 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

IDEAYA Biosciences Market Sentiment

Market sentiment signals for IDEAYA Biosciences (IDYA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 12.5% short float

Options Flow▲ 0.44 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

22 analysts

Options Flow (P/C)

0.44

More calls — Bullish

9 calls · 4 puts

Avg Consensus PT

$52

+30.0%

Highest Price Target

$79

+97.0%

JP Morgan

Lowest Price Target

$27

-32.7%

Leerink Partners

Short Interest

12.5%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 5, 2026	Truist Securities	Gregory Renza—	+47.1%	$63 → $59	Maintained	Buy
Aug 5, 2026	Wedbush	Robert Driscoll—	+49.6%	$58 → $60	Maintained	Outperform
Jul 7, 2026	RBC Capital	Leonid Timashev—	+19.7%	$53 → $48	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+57.1%	$65 → $63	Maintained	Buy
Jun 12, 2026	Wedbush	Robert Driscoll—	+44.6%	$58 → $58	Maintained	Outperform
Jun 2, 2026	Wedbush	Robert Driscoll—	+44.6%	$58 → $58	Maintained	Outperform
May 7, 2026	Mizuho	Graig Suvannavejh—	+24.7%	$52 → $50	Maintained	Outperform
Apr 14, 2026	Goldman Sachs	Corinne Jenkins—	-12.7%	$31 → $35	Maintained	Neutral
Apr 14, 2026	Wells Fargo	Eva Fortea Verdejo—	+19.7%	$44 → $48	Maintained	Overweight
Apr 14, 2026	RBC Capital	Leonid Timashev—	+32.1%	$49 → $53	Maintained	Outperform
Apr 14, 2026	Wedbush	Robert Driscoll—	+44.6%	$52 → $58	Maintained	Outperform
Apr 14, 2026	Guggenheim	Paul Jeng—	+34.6%	$50 → $54	Maintained	Buy
Mar 31, 2026	Wedbush	Robert Driscoll—	+29.6%	$52 → $52	Maintained	Outperform
Feb 19, 2026	Citigroup	Yigal Nochomovitz—	+62.1%	$64 → $65	Maintained	Buy
Feb 18, 2026	RBC Capital	Leonid Timashev—	+22.2%	$49 → $49	Maintained	Outperform
Feb 18, 2026	Guggenheim	Paul Jeng—	+24.7%	$50 → $50	Maintained	Buy
Feb 18, 2026	Wedbush	Robert Driscoll—	+29.6%	$49 → $52	Maintained	Outperform
Jan 21, 2026	RBC Capital	Leonid Timashev—	+12.2%	$41 → $45	Maintained	Outperform
Jan 7, 2026	UBS	Michael Yee—	+24.7%	$50	Assumes	Buy
Jan 6, 2026	Truist Securities	Gregory Renza—	+49.6%	$59 → $60	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+47.1%	$59	Initiate	Buy
Nov 11, 2025	Mizuho	Graig Suvannavejh—	+14.7%	$44 → $46	Maintained	Outperform
Oct 23, 2025	JP Morgan	Anupam Rama—	+97.0%	$74 → $79	Maintained	Overweight
Oct 21, 2025	Goldman Sachs	Corinne Jenkins—	-25.2%	$27 → $30	Maintained	Neutral
Oct 21, 2025	RBC Capital	Leonid Timashev—	+2.2%	$38 → $41	Maintained	Outperform